Skip to content

Metabolic control with glucose-insulin-potassium infusion in acute myocardial infarction (GIPS II).

Metabolic control with glucose-insulin-potassium infusion in acute myocardial infarction (GIPS II).

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25522
Enrollment
900
Registered
2005-08-12
Start date
2003-05-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction eligible for reperfusion therapy.

Interventions

An infusion of 80 mmol potassium chloride in 500 ml 20 percent glucose with a rate of 2 ml/kilogram body weight/hour over an 12 hour period in a peripheral venous line (Appendix 1). The infusion is s

Sponsors

Zwolle, Isala Klinieken, locatie Weezenlanden Dr J.H.E. Dambrink Groningen, Academisch Ziekenhuis Dr S.A.J. van den Broek AMC Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Acute myocardial infarction diagnosed by: 1. Chest pain suggestive for acute myocardial infarction; 2. Symptom-onset 1 mV in 2 or more leads. Patients are eligible for either primary coronary angioplasty or thrombolysis. Patient who has given his or her informed consent to take part in the study.

Exclusion criteria

Exclusion criteria: 1. Unwillingness to participate; 2. Presence of heart failure (either one of these symptoms): a. Heart rate, > 90 beats/min; b. Systolic blood pressure < 100 mmHg with anterior myocardial infarction; c. Killip „d II (third heart sound, „d hand-wide rales).

Design outcomes

Primary

MeasureTime frame
30-day mortality (death from any cause and cardiovascular (death).

Secondary

MeasureTime frame
Secondary endpoints are one-year mortality, and analysis of pre-specified subgroups.

Contacts

Public ContactJ. Klijn

Diagram B.V. Zwolle Dokter Stolteweg 96

j.klijn@diagram-zwolle.nl+31 (0)38 4262997

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)